Karen A Dawes - Net Worth and Insider Trading
Karen A Dawes Net Worth
The estimated net worth of Karen A Dawes is at least $15 Million dollars as of 2024-05-12. Karen A Dawes is the Director of Repligen Corp and owns about 87,367 shares of Repligen Corp (RGEN) stock worth over $15 Million. Karen A Dawes is the Director of Assertio Holdings Inc and owns about 21,147 shares of Assertio Holdings Inc (ASRT) stock worth over $20,301. Karen A Dawes is also the Director of Barinthus Biotherapeutics PLC and owns about 1,700 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $3,970. Details can be seen in Karen A Dawes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karen A Dawes has not made any transactions after 2024-02-27 and currently still holds the listed stock(s).
Transaction Summary of Karen A Dawes
Karen A Dawes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen A Dawes owns 3 companies in total, including Repligen Corp (RGEN) , PDL BioPharma Inc (PDLI) , and Barinthus Biotherapeutics PLC (BRNS) .
Click here to see the complete history of Karen A Dawes’s form 4 insider trades.
Insider Ownership Summary of Karen A Dawes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGEN | Repligen Corp | 2024-02-27 | director |
| PDLI | PDL BioPharma Inc | 2008-04-29 | director & Chairperson of the Board |
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | director |
Karen A Dawes Latest Holdings Summary
Karen A Dawes currently owns a total of 3 stocks. Among these stocks, Karen A Dawes owns 87,367 shares of Repligen Corp (RGEN) as of February 27, 2024, with a value of $15 Million and a weighting of 99.83%. Karen A Dawes owns 21,147 shares of Assertio Holdings Inc (ASRT) as of May 8, 2020, with a value of $20,301 and a weighting of 0.14%. Karen A Dawes also owns 1,700 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 4, 2021, with a value of $3,970 and a weighting of 0.03%.
Latest Holdings of Karen A Dawes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGEN | Repligen Corp | 2024-02-27 | 87,367 | 166.81 | 14,573,689 |
| ASRT | Assertio Holdings Inc | 2020-05-08 | 21,147 | 0.96 | 20,301 |
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | 1,700 | 2.34 | 3,970 |
Holding Weightings of Karen A Dawes
Karen A Dawes Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen A Dawes has made a total of 21 transactions in Repligen Corp (RGEN) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Repligen Corp is the sale of 1,000 shares on February 27, 2024, which brought Karen A Dawes around $193,350.
According to the SEC Form 4 filings, Karen A Dawes has made a total of 2 transactions in Assertio Holdings Inc (ASRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Assertio Holdings Inc is the sale of 3,958 shares on May 8, 2020, which brought Karen A Dawes around $12,509.
According to the SEC Form 4 filings, Karen A Dawes has made a total of 1 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 1,700 shares on May 4, 2021, which cost Karen A Dawes around $28,900.
Insider Trading History of Karen A Dawes
- 1
Karen A Dawes Trading Performance
GuruFocus tracks the stock performance after each of Karen A Dawes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen A Dawes is 3.13%. GuruFocus also compares Karen A Dawes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen A Dawes within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen A Dawes's insider trading performs compared to the benchmark.
Performance of Karen A Dawes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.17 | | | | | |
| Relative Return to S&P 500(%) | 1.42 | | | | | |
Karen A Dawes Ownership Network
Karen A Dawes Owned Company Details
What does Repligen Corp do?
Who are the key executives at Repligen Corp?
Karen A Dawes is the director of Repligen Corp. Other key executives at Repligen Corp include Senior VP & R&D Ralf Kuriyel , director & Chief Executive Officer Anthony Hunt , and SVP & Global Operations & IT James Bylund .
Repligen Corp (RGEN) Insider Trades Summary
Over the past 18 months, Karen A Dawes made 2 insider transaction in Repligen Corp (RGEN) with a net sale of 1,850. Other recent insider transactions involving Repligen Corp (RGEN) include a net sale of 16,707 shares made by Anthony Hunt , a net sale of 5,647 shares made by Jon Snodgres , and a net sale of 4,373 shares made by James Bylund .
In summary, during the past 3 months, insiders sold 25,597 shares of Repligen Corp (RGEN) in total and bought 0 shares, with a net sale of 25,597 shares. During the past 18 months, 35,882 shares of Repligen Corp (RGEN) were sold and 1,500 shares were bought by its insiders, resulting in a net sale of 34,382 shares.
Repligen Corp (RGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repligen Corp Insider Transactions
Karen A Dawes Mailing Address
Above is the net worth, insider trading, and ownership report for Karen A Dawes. You might contact Karen A Dawes via mailing address: 579 Bellevue Ave, Newport Ri 02840.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
